FSMAX
Price
$103.15
Change
+$0.93 (+0.91%)
Updated
Oct 24 closing price
Net Assets
41.44B
NBMTX
Price
$19.62
Change
+$0.16 (+0.82%)
Updated
Oct 24 closing price
Net Assets
2.13B
Interact to see
Advertisement

FSMAX vs NBMTX

Header iconFSMAX vs NBMTX Comparison
Open Charts FSMAX vs NBMTXBanner chart's image
Fidelity Extended Market Index
Price$103.15
Change+$0.93 (+0.91%)
VolumeN/A
Net Assets41.44B
Neuberger Berman Mid Cap Growth Tr
Price$19.62
Change+$0.16 (+0.82%)
VolumeN/A
Net Assets2.13B
FSMAX vs NBMTX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. NBMTX commentary
Oct 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Buy and NBMTX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 41.4B vs. NBMTX (2.13B). FSMAX pays higher dividends than NBMTX: FSMAX (0.44) vs NBMTX (0.00). FSMAX was incepted earlier than NBMTX: FSMAX (14 years) vs NBMTX (32 years). NBMTX (0.94) is less costly to investors than FSMAX (0.04). NBMTX is a more actively managed with annual turnover of: 97.00 vs. FSMAX (15.00). FSMAX (0) and NBMTX (0) have matching initial minimum investment requirements. FSMAX annual gain was more profitable for investors over the last year : 16.43 vs. NBMTX (7.16). FSMAX return over 5 years is better than : 51.38 vs. NBMTX (-2.01).
FSMAXNBMTXFSMAX / NBMTX
Total Expense Ratio0.040.944%
Annual Report Gross Expense Ratio0.040.944%
Fund Existence14 years32 years-
Gain YTD12.47814.24688%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets41.4B2.13B1,940%
Annual Yield % from dividends0.440.00-
Returns for 1 year16.437.16229%
Returns for 3 years62.3241.35151%
Returns for 5 years51.38-2.01-2,559%
Returns for 10 years108.6643.32251%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SCINX63.54N/A
N/A
DWS CROCI International S
ANOAX21.58N/A
N/A
American Century Small Cap Growth A
ETAHX41.71N/A
N/A
Eventide Healthcare & Life Sciences A
NELIX67.06N/A
N/A
Nuveen Equity Long/Short I
CESGX12.12N/A
N/A
Coho Relative Value ESG